{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:47:24Z","timestamp":1766155644937,"version":"3.48.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Idiopathic inflammatory myopathies (IIM) are rare autoimmune diseases that may complicate pregnancy, but evidence remains scarce. Disease activity at conception and during gestation, together with autoantibody profiles, are considered major determinants of adverse pregnancy outcomes (APOs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicentre study of 12 pregnancies in 10 women with IIM followed at four Portuguese tertiary centers (2009\u20132025). Demographic, clinical, immunological, therapeutic, maternal, and perinatal data were collected from medical records. Disease activity was assessed by clinical features, laboratory data, modified skin Disease Activity Score, and Manual Muscle Testing-8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Phenotypes included overlap myositis (\n                      <jats:italic>n<\/jats:italic>\n                      = 4), antisynthetase syndrome (\n                      <jats:italic>n<\/jats:italic>\n                      = 3), dermatomyositis (\n                      <jats:italic>n<\/jats:italic>\n                      = 3), immune-mediated necrotising myopathy (\n                      <jats:italic>n<\/jats:italic>\n                      = 1), and polymyositis (\n                      <jats:italic>n<\/jats:italic>\n                      = 1). Myositis-specific\/associated autoantibodies were detected in 91.7% of the cases, most frequently anti-Ro52 and anti-Jo-1. Disease remission at conception was documented in nine pregnancies (75.0%). Overall, APOs occurred in six pregnancies (50.0%): four miscarriages, one stillbirth, and one fetal growth restriction (FGR) with a small-for-gestational-age neonate. Of the 12 pregnancies, seven resulted in live births. All APOs occurred in pregnancies with disease flares, none occurred when disease remained stable. Among pregnancies with known preconception status, APOs occurred both in pregnancies conceived under active disease and in some conceived during remission. The most severe outcomes (stillbirth, FGR) occurred in one mother with antisynthetase syndrome and markedly elevated anti-Jo-1 titres. No cases of preeclampsia, eclampsia, congenital anomalies, or neonatal lupus were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this cohort, APOs were frequent, particularly among pregnancies complicated by disease activity. Although remission at conception was common, it did not fully prevent flares or obstetric complications. Anti-Jo-1 positivity appeared to cluster among the more severe cases, suggesting potential clinical relevance for monitoring. Multidisciplinary care and preconception optimization remain essential. Larger multicentre registries will be crucial to improving understanding and management of pregnancy in IIM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1724170","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:39:33Z","timestamp":1766155173000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy outcomes in idiopathic inflammatory myopathies: a Portuguese multicentre study"],"prefix":"10.3389","volume":"12","author":[{"given":"Ana Rita","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Teod\u00f3sio Ch\u00edcharo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Campanilho-Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Dias","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Param\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia C.","family":"Barreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pulido-Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Cruz-Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Capela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1439807","DOI":"10.3389\/fimmu.2024.1439807","article-title":"Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/rheumatology\/kex070","article-title":"Pregnancy in polymyositis or dermatomyositis: retrospective results from a tertiary centre in China","volume":"56","author":"Zhong","year":"2017","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00296-006-0239-8","article-title":"Pregnancy outcome in idiopathic inflammatory myopathy","volume":"27","author":"V\u00e1ncsa","year":"2007","journal-title":"Rheumatol Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bpobgyn.2019.10.004","article-title":"Pregnancy in myositis and scleroderma","volume":"64","author":"Munira","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e33462","DOI":"10.1097\/MD.0000000000033462","article-title":"Pregnancy course and outcomes of patients with polymyositis and dermatomyositis (PM\/DM) managed in a single center","volume":"102","author":"Mino","year":"2023","journal-title":"Medicine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-212786","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","volume":"70","author":"Lam","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bpobgyn.2011.02.006","article-title":"Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae","volume":"25","author":"Romero","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/AOG.0000000000001711","article-title":"Management of preterm labor: Practice Bulletin 171","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3899\/jrheum.140438","article-title":"Pregnancy outcome in idiopathic inflammatory myopathy patients in a multicenter study","volume":"41","author":"Nagy-Vincze","year":"2014","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1449390","DOI":"10.3389\/flupu.2024.1449390","article-title":"High fetal risk in pregnancies of myositis patients: a Hungarian cohort study","volume":"2","author":"Nagy-Vincze","year":"2024","journal-title":"Front Lupus."},{"key":"B17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/art.1780270307","article-title":"Polymyositis\/dermatomyositis and pregnancy","volume":"27","author":"Guti\u00e9rrez","year":"1984","journal-title":"Arthritis Rheum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/rheumatology\/keg318","article-title":"Pregnancy outcome in adult-onset idiopathic inflammatory myopathy","volume":"42","author":"Silva","year":"2003","journal-title":"Rheumatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.semarthrit.2017.11.005","article-title":"Pregnancy outcomes in adult patients with dermatomyositis and polymyositis","volume":"47","author":"Kolstad","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1515\/jpm-2021-0361","article-title":"Maternal and neonatal outcomes among pregnant women with inflammatory myopathies","volume":"50","author":"Tuccinardi","year":"2022","journal-title":"J Perinat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1093\/rheumatology\/kez666","article-title":"Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis-a population-based study","volume":"59","author":"Che","year":"2020","journal-title":"Rheumatology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1191\/0961203304lu1098oa","article-title":"Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Be\u00e7het disease","volume":"13","author":"Doria","year":"2004","journal-title":"Lupus."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00296-021-04851-1","article-title":"Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy","volume":"42","author":"Akiyama","year":"2022","journal-title":"Rheumatol Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.jbspin.2025.105932","article-title":"Treatment of idiopathic inflammatory myopathies","volume":"92","author":"Campanilho-Marques","year":"2025","journal-title":"Joint Bone Spine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12931-024-02851-w","article-title":"Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome","volume":"25","author":"Yang","year":"2024","journal-title":"Respir Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13603","DOI":"10.1111\/aji.13603","article-title":"Pregnancy in adult-onset dermatomyositis\/polymyositis: A systematic review","volume":"88","author":"Tang","year":"2022","journal-title":"Am J Reprod Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/AOG.0000000000002709","article-title":"743 summary: low-dose aspirin use during pregnancy","volume":"132","author":"ACOG","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/jth.15290","article-title":"Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?","volume":"19","author":"Hamuly\u00e1k","year":"2021","journal-title":"J Thromb Haemost."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1724170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:39:33Z","timestamp":1766155173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1724170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":30,"alternative-id":["10.3389\/fmed.2025.1724170"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1724170","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"1724170"}}